Northwestern Mutual Wealth Management’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8 | Hold |
341
| – | – | ﹤0.01% | 3631 |
|
|
2025
Q1 | $17 | Hold |
341
| – | – | ﹤0.01% | 3612 |
|
|
2024
Q4 | $17 | Hold |
341
| – | – | ﹤0.01% | 3549 |
|
|
2024
Q3 | $17 | Hold |
341
| – | – | ﹤0.01% | 3552 |
|
|
2024
Q2 | $14 | Buy |
341
+99
| +41% | +$4 | ﹤0.01% | 3453 |
|
|
2024
Q1 | $13 | Hold |
242
| – | – | ﹤0.01% | 3523 |
|
|
2023
Q4 | $22 | Hold |
242
| – | – | ﹤0.01% | 3425 |
|
|
2023
Q3 | $23 | Hold |
242
| – | – | ﹤0.01% | 3240 |
|
|
2023
Q2 | $27 | Hold |
242
| – | – | ﹤0.01% | 3304 |
|
|
2023
Q1 | $29 | Hold |
242
| – | – | ﹤0.01% | 3300 |
|
|
2022
Q4 | $29 | Hold |
242
| – | – | ﹤0.01% | 3265 |
|
|
2022
Q3 | $0 | Hold |
242
| – | – | ﹤0.01% | 3143 |
|
|
2022
Q2 | $0 | Hold |
242
| – | – | ﹤0.01% | 3202 |
|
|
2022
Q1 | $0 | Hold |
242
| – | – | ﹤0.01% | 3130 |
|
|
2021
Q4 | $0 | Hold |
242
| – | – | ﹤0.01% | 3151 |
|
|
2021
Q3 | $0 | Hold |
242
| – | – | ﹤0.01% | 3031 |
|
|
2021
Q2 | $0 | Hold |
242
| – | – | ﹤0.01% | 3017 |
|
|
2021
Q1 | $0 | Hold |
242
| – | – | ﹤0.01% | 2785 |
|
|
2020
Q4 | $0 | Hold |
242
| – | – | ﹤0.01% | 2707 |
|
|
2020
Q3 | $0 | Hold |
242
| – | – | ﹤0.01% | 2542 |
|
|
2020
Q2 | $0 | Hold |
242
| – | – | ﹤0.01% | 2422 |
|
|
2020
Q1 | $0 | Hold |
242
| – | – | ﹤0.01% | 2571 |
|
|
2019
Q4 | $0 | Buy |
+242
| New | – | ﹤0.01% | 2409 |
|